4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-024000
Director acquired 40,258 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yanai Shlomo Director | 2025-05-05 | Option exercise | +40,258 | 285,985 | D | ||
| Derivatives | |||||||
| Yanai Shlomo Director | 2025-05-05 | Option exercise · Restricted Stock Units | −40,258 | 0 | D | ||
| Yanai Shlomo Director | 2025-05-06 | Grant or award · Restricted Stock Units | +34,819 | 34,819 | D | ||
Loading xslF345X05/wk-form4_1746747275.xml…